# Clinical Study on the Treatment of Lower Respiratory Tract Infection With Pseudomonas Aeruginosa by Ceftazidime and Avibatam

> **NCT06992102** · — · COMPLETED · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 500 (actual)

## Conditions studied

- MDRPA

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06992102
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06992102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06992102, "Clinical Study on the Treatment of Lower Respiratory Tract Infection With Pseudomonas Aeruginosa by Ceftazidime and Avibatam". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT06992102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*